Press Release Jun 03 2026
Filed with NSE · · 2 pages · English
Earlier from Lupin
- Lupin Receives Approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets
- Press Release May 29 2026
- Lupin Shares Phase 1 Data on LNP8701 at the ASCO Annual Meeting 2026
- Press Release May 28 2026
- Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension
Later from Lupin
- Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
- Press Release Jun 04 2026
- Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
- Press Release Jun 08 2026
- Lupin Launches Azilsartan Medoxomil Tablets in the United States
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin